P/B
2,7
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
$8.6B
Market Cap • 10/16/2026
2008
(18 years)
Founded
2025
(1 year ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
8,7
P/EBITDA
49,6
P/OCF
51,2
P/FCF
69,7
P/E
84,9
BVPS
11,1
EPS
0,4
Market Cap
Market Cap
8,6B
EV
8,2B
EV/Revenue
8,3
EV/EBITDA
47,3
EV/EBIT
53,7
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
0,4%
Total Yield
0,4%
Payout
0%
Profitability
Gross Margin
69,7%
EBITDA Margin
17,6%
EBIT Margin
15,5%
Net Margin
10,6%
D&A/EBITDA
0%
R&D/Revenue
11,8%
Capex/Revenue
4,5%
Capex/D&A
214,8%
Capex/OCF
26,5%
SBC/OCF
38,6%
% PPE
7,8%
% Goodwill
1,6%
ROE
5,8%
ROIC
79%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
5,5
Quick Ratio
4,8
Interest Coverage
326,8%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!